SNS Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,110
Closed -$870K – 553
2026
Q1
$870K Sell
12,110
-104
-0.9% -$8.01K 0.07% 92
2025
Q4
$969K Sell
12,214
-375
-3% -$29.6K 0.08% 86
2025
Q3
$949K Sell
12,589
-199
-2% -$13.6K 0.08% 88
2025
Q2
$882K Buy
12,788
+311
+2% +$20.4K 0.08% 91
2025
Q1
$845K Buy
12,477
+305
+3% +$18.3K 0.09% 93
2024
Q4
$546K Sell
12,172
-2,613
-18% -$147K 0.06% 107
2024
Q3
$930K Sell
14,785
-688
-4% -$40.1K 0.09% 93
2024
Q2
$914K Buy
+15,473
New +$968K 0.1% 90
2019
Q1
– Sell
-3,363
Closed -$220K – 195
2018
Q4
$220K Sell
3,363
-39
-1% -$2.91K 0.05% 162
2018
Q3
$268K Sell
3,402
-104
-3% -$7.43K 0.06% 145
2018
Q2
$226K Buy
3,506
+30
+0.9% +$1.98K 0.06% 151
2018
Q1
$216K Sell
3,476
-463
-12% -$33.2K 0.06% 146
2017
Q4
$286K Buy
3,939
+354
+10% +$25.7K 0.07% 144
2017
Q3
$292K Sell
3,585
-41
-1% -$3.24K 0.07% 134
2017
Q2
$292K Sell
3,626
-395
-10% -$31.2K 0.08% 131
2017
Q1
$316K Buy
+4,021
New +$321K 0.08% 134

Other funds holding CVS

SNS Financial Group's CVS Position: Q2 2026 in Review

SNS Financial Group sold out of CVS Health (CVS) in Q2 2026, closing a stake of 12,110 shares — an estimated $870K sold.

SNS Financial Group first reported a position in CVS in Q1 2017 and held it in 16 quarters. The position peaked at $969K in Q4 2025. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • SNS Financial Group reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • SNS Financial Group sold 12,110 CVS Health shares in Q2 2026, an estimated $870K.
  • SNS Financial Group first reported a position in CVS Health in Q1 2017 and held it in 16 quarters.
  • SNS Financial Group's CVS Health position peaked at $969K in Q4 2025.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.